Publications by authors named "Bryan A Faller"

Claim this Profile
P
Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929.
Nagla Abdel Karim, Jieling Miao, Karen L Reckamp, Carl M Gay, Lauren A Byers, Bryan A Faller

J Thorac Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
Howard S Hochster, Paul Catalano, Michelle Weitz, Edith P Mitchell, Deirdre Cohen, Bryan A Faller

J Natl Cancer Inst· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma.
William A Hall, Jiahe Li, Y Nancy You, Marc J Gollub, Joseph R Grajo, Bryan A Faller

J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of Risk Factors for Unplanned Hospitalization in Older Adults With Advanced Cancer Receiving Chemotherapy.
Mostafa R Mohamed, Kah Poh Loh, Supriya G Mohile, Michael Sohn, Tracy Webb, Bryan A Faller

J Natl Compr Canc Netw· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152).
Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, Shuli Li, Ilana F Gareen, Bryan A Faller

Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.
Roisin M Connolly, Fengmin Zhao, Kathy D Miller, Min-Jung Lee, Richard L Piekarz, Bryan A Faller

J Clin Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial.
Osama E Rahma, Greg Yothers, Theodore S Hong, Marcia M Russell, Y Nancy You, Bryan A Faller

JAMA Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.
Thomas A Hensing, Xiaofei Wang, Thomas E Stinchcombe, Junheng Gao, Michael V Knopp, Bryan A Faller

JTO Clin Res Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).
Athanassios Argiris, Jieling Miao, Mihaela C Cristea, Allen M Chen, Jacob M Sands, Bryan A Faller

Clin Lung Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial.
Alain P Algazi, Megan Othus, Adil I Daud, Roger S Lo, Janice M Mehnert, Bryan A Faller

Nat Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancer.
Bryan A Faller, Trailokya N Pandit

Clin Med Insights Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac tamponade or hemopericardium are not associated with bleeding risk factors in consecutive patients hospitalized with noniatrogenic, pericardial effusions.
Bryan A Faller, Qin Zhang, Joel Picus

Am J Hematol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy.
Bryan A Faller, Barbara Burtness

Biologics· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related acute myelogenous leukemia with an 11q23/MLL translocation following adjuvant cisplatin and vinorelbine for non-small-cell lung cancer.
Bryan A Faller, Valentin G Robu, Hossein Borghaei

Clin Lung Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Images in clinical medicine. New-onset clubbing associated with lung cancer.
Bryan A Faller, John P Atkinson

N Engl J Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis